Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Summit Therapeutics (SMMT) Gross Margin: 2016-2024

Historic Gross Margin for Summit Therapeutics (SMMT) over the last 5 years, with Dec 2024 value amounting to 100.00%.

  • Summit Therapeutics' Gross Margin was N/A to 100.00% in Q4 2024 from the same period last year, while for Dec 2024 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Summit Therapeutics' Gross Margin amounted to 100.00% in Q4 2024, which was down 0.00% from 100.00% recorded in Q3 2024.
  • In the past 5 years, Summit Therapeutics' Gross Margin registered a high of 100.00% during Q1 2020, and its lowest value of 100.00% during Q1 2020.
  • Over the past 2 years, Summit Therapeutics' median Gross Margin value was 100.00% (recorded in 2024), while the average stood at 100.00%.